The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study
Tarih
2021Yazar
OYAN ULUÇ, Başak
Ozkan, Berker
Yenigun, Mustafa B.
Yilmazbayhan, Dilek
Toker, Alper
Ferhatoglu, Ferhat
Yasar, Arzu
SAK, SERPİL
Tanju, Serhan
Dilege, Sukru
Erus, Suat
Bulutay, Pinar
Firat, Pinar
Mandel, Nil Molinas
Kilickap, Sadettin
Onder, Sevgen
DİKMEN, ERKAN
Alan, Ozkan
Yumuk, Perran F.
BOZKURTLAR, EMİNE
LAÇİN, TUNÇ
YILDIZELİ, BEDRETTİN
Ozturk, Akin
Ak, Naziye
Eralp, Yesim
Urer, Nur
Aydiner, Adnan
DEMİRKAZIK, AHMET
Kocaturk, Celalettin
Karapinar, Kemal
Üst veri
Tüm öğe kaydını gösterÖzet
Purpose: The benefit of adjuvant chemotherapy for tumors smaller than 4 cm is not clear. We aimed to evaluate the prognostic impact of adjuvant platin-based chemotherapy in high-risk stage I patients with non-small cell lung cancer (NSCLC).
Koleksiyonlar
- Makale [92796]